GEODE CAPITAL MANAGEMENT, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 171 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$21,992,333
-19.8%
3,372,322
+7.2%
0.00%
-33.3%
Q1 2024$27,415,387
-22.2%
3,147,158
+2.2%
0.00%
-25.0%
Q4 2023$35,244,364
+25.1%
3,080,463
+5.3%
0.00%
+33.3%
Q3 2023$28,162,750
-5.2%
2,924,123
+4.7%
0.00%0.0%
Q2 2023$29,709,922
+7.2%
2,792,285
+6.0%
0.00%
-25.0%
Q1 2023$27,707,629
+88809.1%
2,633,804
+4.7%
0.00%0.0%
Q4 2022$31,164
-99.9%
2,515,290
+2.0%
0.00%0.0%
Q3 2022$25,543,000
-15.3%
2,465,627
-5.7%
0.00%0.0%
Q2 2022$30,151,000
-13.1%
2,615,039
-5.2%
0.00%0.0%
Q1 2022$34,704,000
+7.7%
2,758,736
-0.2%
0.00%0.0%
Q4 2021$32,223,000
-12.2%
2,763,568
-1.7%
0.00%
-20.0%
Q3 2021$36,716,000
+3.5%
2,811,404
+2.0%
0.01%0.0%
Q2 2021$35,487,000
+14.3%
2,757,409
-0.7%
0.01%0.0%
Q1 2021$31,039,000
+10.1%
2,776,343
+12.2%
0.01%0.0%
Q4 2020$28,181,000
+32.9%
2,474,244
+5.0%
0.01%
+25.0%
Q3 2020$21,204,000
-15.0%
2,357,467
-2.5%
0.00%
-20.0%
Q2 2020$24,944,000
+7.8%
2,417,077
+5.4%
0.01%
-16.7%
Q1 2020$23,132,000
-60.4%
2,292,646
-47.8%
0.01%0.0%
Q4 2019$58,406,000
+214.8%
4,388,176
+103.1%
0.01%
+50.0%
Q3 2019$18,552,000
-20.2%
2,161,004
+1.7%
0.00%
-33.3%
Q2 2019$23,237,000
-11.6%
2,124,100
+9.4%
0.01%
-14.3%
Q1 2019$26,274,000
-23.6%
1,941,979
-41.5%
0.01%
+40.0%
Q4 2018$34,368,000
+19.0%
3,317,508
+112.1%
0.01%
-37.5%
Q3 2018$28,876,000
+6.1%
1,564,301
+9.9%
0.01%0.0%
Q2 2018$27,222,000
+37.5%
1,423,792
+11.0%
0.01%
+33.3%
Q1 2018$19,792,000
+6.5%
1,282,719
+3.5%
0.01%0.0%
Q4 2017$18,586,000
-2.5%
1,239,906
+2.6%
0.01%
-14.3%
Q3 2017$19,066,000
-15.5%
1,209,005
+1.2%
0.01%
-22.2%
Q2 2017$22,560,000
+15.1%
1,194,961
+4.0%
0.01%
+12.5%
Q1 2017$19,605,000
+23.0%
1,149,205
+10.3%
0.01%
+14.3%
Q4 2016$15,935,000
+1.6%
1,042,193
+5.5%
0.01%
-12.5%
Q3 2016$15,686,000
+25.8%
987,867
+3.5%
0.01%
+14.3%
Q2 2016$12,473,000
+22.2%
954,033
+2.3%
0.01%
+40.0%
Q1 2016$10,204,000
+0.7%
932,729
+6.6%
0.01%
-16.7%
Q4 2015$10,136,000
+17.4%
874,584
+5.5%
0.01%
+20.0%
Q3 2015$8,636,000
-7.0%
828,822
+7.6%
0.01%0.0%
Q2 2015$9,288,000
-23.1%
770,255
+2.1%
0.01%
-28.6%
Q1 2015$12,073,000
+10.1%
754,644
+5.4%
0.01%0.0%
Q4 2014$10,967,000
+21.2%
715,886
+2.5%
0.01%
+16.7%
Q3 2014$9,046,000
-14.7%
698,339
+1.0%
0.01%
-14.3%
Q2 2014$10,600,000
+29.8%
691,472
+4.3%
0.01%
+40.0%
Q1 2014$8,169,000
+36.9%
663,089
+29.0%
0.01%
+25.0%
Q4 2013$5,965,000
+7.7%
513,860
+10.0%
0.00%0.0%
Q3 2013$5,538,000
+35.6%
467,321
+13.9%
0.00%0.0%
Q2 2013$4,083,000410,3750.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$183,240,00017.56%
HealthInvest Partners AB 1,450,000$16,211,00012.91%
Healthcare Value Capital, LLC 200,000$2,236,0004.98%
BRIDGER MANAGEMENT, LLC 2,852,414$31,890,0002.98%
Camber Capital Management LP 7,500,000$83,850,0002.88%
13D Management LLC 658,017$7,357,0002.72%
Brown Capital Management 20,170,126$225,502,0001.68%
Healthcare Value Capital, LLC 50,000$559,0001.24%
Zebra Capital Management LLC 59,122$661,0000.73%
PRICE MICHAEL F 520,000$5,814,0000.70%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders